The accumulation of the scrapie agent in lymphoid tissues following inoculation via the skin is critical for efficient neuroinvasion, but how the agent is initially transported from the skin to the draining lymph node is not known. Langerhans cells (LCs) are specialized antigen-presenting cells that continually sample their microenvironment within the epidermis and transport captured antigens to draining lymph nodes. We considered LCs probable candidates to acquire and transport the scrapie agent after inoculation via the skin. XS106 cells are dendritic cells (DCs) isolated from mouse epidermis with characteristics of mature LC cells. To investigate the potential interaction of LCs with the scrapie agent XS106 cells were exposed to the scrapie agent in vitro. We show that XS106 cells rapidly acquire the scrapie agent following in vitro exposure. In addition, XS106 cells partially degrade the scrapie agent following extended cultivation. These data suggest that LCs might acquire and degrade the scrapie agent after inoculation via the skin, but data from additional experiments demonstrate that this ability could be lost in the presence of lipopolysaccharide or other immunostimulatory molecules. Our studies also imply that LCs would not undergo maturation following uptake of the scrapie agent in the skin, as the expression of surface antigens associated with LC maturation were unaltered following exposure. In conclusion, although LCs or DCs have the potential to acquire the scrapie agent within the epidermis our data suggest it is unlikely that they become activated and stimulated to transport the agent to the draining lymph node.
Introduction
The transmissible spongiform encephalophathies (TSEs or prion diseases) are infectious, fatal, neurodegenerative diseases. During disease, PrP Sc , an abnormal, relatively proteinase-resistant isoform of the host glycoprotein PrP C accumulates with infectivity in affected tissues. 1 PrP Sc is considered to constitute a major, or possibly sole component of the infectious TSE agent. 2 The deposition of PrP Sc within the brains of most TSE-affected hosts is usually accompanied with neurodegeneration.
Many natural infections with TSE agents, such as natural sheep scrapie, bovine spongiform encephalopathy, chronic wasting disease in mule deer and elk and variant Creutzfeldt-Jakob disease (vCJD) in humans, are likely to be acquired orally.
However, studies in mice show that skin scarification is also an effective means of scrapie transmission. 3 This suggests that some natural TSE cases might be transmitted through skin lesions in the mouth 4 or through sites of skin trauma during close contact with infected animals. The potential to transmit vCJD in humans iatrogenically during surgical or dental procedures is a current concern.
Following inoculation of mice with the scrapie agent via the skin, 5, 6 peritoneal cavity 7, 8 or orally 9 neuroinvasion usually occurs after the agent accumulates in association with follicular dendritic cells (FDCs) in the germinal centres of lymphoid tissues.
How TSE agents are transported initially from the site of exposure, such as the gastrointestinal tract or the skin, to the germinal centres where they replicate is not known. FDCs could directly trap PrP Sc or other agent-associated molecules in a complement-bound complex. 10, 11 TSE agents might also be delivered to germinal centres following their uptake and transportation by mobile cells. Migratory bone marrow-derived DCs are a distinct lineage from tissue-fixed, stromal-derived FDCs. 12 These DCs circulate continually throughout the host's tissues and tissue fluids sampling antigens and transporting them to lymphoid tissues. 13 Langerhans cells (LCs) are a subset of migratory DCs that are situated within the epidermis and migrate to the draining lymph node following antigen encounter. 13 DCs and LCs are considered to provide potential mechanisms for the transmission of some viruses into the skin. 14, 15 A subpopulation of migratory DCs might also play a role in the transportation of PrP Sc from the intestine to the mesenteric lymph node. 16 These observations suggested to us that LCs were plausible candidates for the transportation of the scrapie agent from the skin to draining lymph nodes. XS106 cells are a well-established DC cell line isolated from mouse epidermis with characteristics of mature LCs. These cells strongly resemble LCs in vivo and potently activate naive T lymphocytes in allogeneic mixed lymphocyte reactions. 17 Our preliminary investigations suggested that XS106 cells had the potential to acquire and degrade PrP Sc . 18 In the current study these cells were used to further explore the potential interactions of LCs with the scrapie agent following in vitro exposure.
Materials and metodhs

Culture of cell lines
The XS52 and XS106 cell lines (kind gifts from Professor Akira Takashima, University of Texas South-western, TX) are long-established dendritic cell lines derived from the epidermis of newborn mice. 17, 19 These cell lines were cultured in complete RPMI-1640 medium (cRPMI) which contained 2 mM L-glutamine, 1 mM sodium pyruvate, 10 mM HEPES buffer, 0·25 µg/ml antibiotic-antimycotic solution (A5955, containing penicillin, streptomycin and amphotericin B), 50 µM 2-β-mercaptoethanol, 1% non-essential amino acids (all from Sigma, Poole) and 10% heat-inactivated fetal calf serum (Invitrogen, Paisley). The medium used to cultivate the XS52 cells was supplemented further with 2 ng/ml murine recombinant granulocyte-macrophage colony stimulating factor (GM-CSF; R&D Systems, Abingdon, Oxon) and 10% (v/v) culture supernatant derived from the NS47 fibroblast cell line. The medium used to cultivate the XS106 cells was supplemented with 0·5 ng/ml murine recombinant GM-CSF and 5% (v/v) culture supernatant derived from the NS47 fibroblast cell line. All cell lines were cultured at 37° in a 5% CO2/air atmosphere.
Upon receipt, cells were passaged four times to obtain a large batch culture and then cryopreserved. For each individual experiment a new vial of cells was revived and expanded for 10 days in culture prior to use to ensure homogeneity between cell populations.
Flow cytometry
Cells were harvested and viable cell numbers determined by trypan blue dye exclusion. Cells were pelleted (300 g for 10 min at 4°) and resuspended in FACS buffer [phosphate buffered saline (PBS) pH 7·4 containing 0·1% bovine serum albumin (BSA), 0·1% sodium azide and 0·02% ethylene diamine tetra-acetic acid (Caltag). Avidin/biotin binding sites were blocked subsequently using the avidin/biotin blocking kit (Vector Laboratories, Peterborough) according to the manufacturer's instructions. PrP was detected using the PrP-specific mouse mAb 8H4 20 followed by biotin-conjugated goat antimouse antibody (Jackson ImmunoResearch Laboratories, West Grove, PA). Immunolabelling was carried out using Alexa 488-conjugated streptavidin (Biosciences, Cambridge). Cell nuclei were distinguished using DAPI nucleic acid stain (Biosciences).
Cell immunoblot detection of PrP Sc
PrP Sc accumulations were determined by the cell immunoblot procedure. 21 Briefly, coverslips were removed and the cell-bearing side blotted onto polyvinylidine difluoride membranes (Bio-Rad, Hemel Hempstead), treated with proteinase K, denatured with guanidine isothiocyanate and PrP detected using the PrP-specific mAb 8H4. 20 Immunolabelling was carried out using horseradish peroxidaseconjugated goat antimouse IgG antiserum (Jackson ImmunoResearch Laboratories Inc.), and bound horseradish peroxidase activity detected with Supersignal ® West Dura Extended Duration Substrate (Pierce, Chester). After exposure, membranes were stained with 0·5 µg/ml ethidium bromide and observed in UV light to confirm transfer of the cell layer. 22 Determination of scrapie agent infectivity Following exposure to the scrapie agent for the times indicated cells were dislodged using a rubber policeman and washed twice in Hanks's balanced salt solution (HBSS). Viable cell numbers were determined by trypan blue dye exclusion. Cell pellets were resuspended in an appropriate volume of sterile PBS to give 2 × 10 5 cells per 20 µl dose. Cells were lysed by 10 successive rapid freeze-thaw cycles at the temperature of liquid nitrogen. Non-infected cells or cells exposed to normal brain homogenate were used as reference controls. Cell lysates (20 µl) were injected intracranially (i.c.) into groups of nine C57BL/Dk indicator mice. The scrapie titre in each lysate was estimated from the mean incubation period from a dose/incubation period response curve for scrapie-infected spleen tissue. 23 Infectivity titres are expressed as 50% infectious dose units per 10 6 cells (ID50/10 6 cells).
Statistical tests
Data from individual experiments are presented and are representative of data from two to five experiments. Where applicable, the statistical significance of differences between the means for each experimental group were calculated using ANOVA oneway analysis with Minitab software. A P-value = 0·05 was considered to be significantly different.
Results
Characterization of the XS106 cell line
Prior to use in experiments the surface phenotype of the XS106 cells was determined.
FACS analysis confirmed that the XS106 cells expressed the following surface markers: CD11c, CD40, CD54, CD80, CD86, CD205 and Ia k (MHC-II) (Fig. 1b- FACs analysis demonstrated that the majority of the XS106 cells expressed PrP C protein on their surfaces (Fig. 1i) . The expression of PrP-specific mRNA was confirmed using two different sets of primers by the visualization of a single band at 1000 bp using primer combination 1 (Fig. 1j, lanes 1 and 2) and also a single band at 400 bp using primer combination 2 (Fig. 1j, lanes 3 and 4) .
XS106 cells rapidly acquire scrapie-affected brain homogenate
We next determined whether XS106 cells could acquire the scrapie agent after in vitroexposure. Cells were exposed to terminally scrapie-affected brain homogenate for 10 min, 30 min, 16 hr or 24 hr. Uninfected cells and cells exposed to an equivalent amount of uninfected (normal) brain homogenate were included as controls.
Immunofluorescent confocal analysis of cytospin preparations revealed abundant accumulations of PrP in association with the XS106 cells within 10 min of exposure to scrapie-affected brain homogenate (Fig. 2, panel c) . Visually, the strongest labelling for PrP was detected after 30 min of exposure to the scrapie brain homogenate (Fig. 2, panel f) . Thereafter, the intensity of PrP staining appeared to decrease during the 24-hr observation period (Fig. 2 , panels i and l). Accumulations of PrP were also detected in association with XS106 cells exposed to normal brain homogenate over the same time period (Fig. 2, panels, b , e, h and k). In contrast, the level of PrP immunolabelling detected in association with unexposed cells (Fig. 2, panels a, d, g and j) was visibly less when compared to cells exposed to either scrapie brain homogenate or normal brain homogenates. Thus, these data appear to show that XS106 cells rapidly acquire scrapie-affected and normal brain homogenate after in vitro exposure. However, as the PrP-specific mAb 8H4 does not distinguish between the cellular PrP C or scrapie agent-specific PrP Sc isoforms, it was not possible to determine immunocytochemically whether the PrP detected was PrP Sc , PrP C from the brain homogenate or enhanced expression of PrP C by XS106 cells in response to the brain homogenate. (Fig. 3a) . However, analysis of cells from 48 hr onwards suggested that the levels of PrP Sc detected progressively decreased over the 96-hr observation period (Fig. 3a 18 ). In contrast, no PrP Sc was detected in association with cells exposed to normal brain homogenate (Fig. 3a) or unexposed cells (Fig. 3c) as controls. The successful transfer of cells to the membranes was confirmed by the detection of cellular DNA on membranes for each cell transfer (Fig. 3b) . No PrP Sc or DNA was detected in association with cell-free cover-slips exposed to scrapie brain homogenate as a control (Fig. 3d) , confirming that the PrP Sc detected in the above instances (Fig. 3a) was cell-associated and not simply adhered to the coverslip. No significant effect on cell viability or metabolic activity was observed following exposure of the cells to scrapie brain homogenate when compared to those exposed to normal brain homogenate or medium alone, as controls (data not shown). Thus the reduction in the PrP Sc associated with the XS106 LC-like cells was unlikely to be due to reduced cell viability. A further experiment was included to determine whether the reduced detection of PrP Sc in association with XS106 cells was due to masking the epitope recognized by mAb 8H4. The PrP-specific mAb 7A12 recognizes an epitope contained within amino acid residues 122-143 of the PrP protein which is distinct from the epitope recognized by mAb 8H4 (amino acids 147-164 20 ). The level of PrP Sc detected following exposure of XS106 cells to scrapie brain homogenate was similarly visibly reduced over the 96-hr observation period when mAb 7A12 was used to detect PrP Sc (Fig. 3e) .
To determine whether the degradation of PrP Sc by XS106 cells correlated with a reduction in scrapie infectivity, lysates were prepared from XS106 cells exposed to scrapie-affected brain homogenate and infectivity titres determined by incubation period assay by i.c. injection into nine C57BL/Dk indicator mice. Lysates prepared from uninfected XS106 cells and cells exposed to normal brain homogenate were included as negative controls. After 16 hr exposure to scrapie brain homogenate the cells had acquired approximately 5·9 log i.c. ID50/10 6 cells (Fig. 4a) . Statistical analysis of the means of the disease incubation periods for each group of indicator mice injected with homogenate prepared 16 hr (190 ± 2 days, n = 9) or 24 hr (188 ± 3 days, n = 9) after exposure suggested there was no significant difference between the infectivity titres associated with these cells at 16 hr and 24 hr postexposure (P = 0·659,ANOVA, n = 9). However, by 96 hr after exposure the infectivity titre had declined to approximately 4·4 log i.c. ID50/10 6 cells (Fig. 4a) . Comparison of the mean disease incubation period obtained from mice injected with 96-hr homogenates (220 ± 9 days,n = 9) with those measured at both 16 hr and 24 hr postexposure suggested the infectivity titre measured after 96 hr exposure was significantly lower (P = 0·007 andP = 0·008, respectively, ANOVA, n = 9). Scrapie infectivity was undetectable in preparations of normal brain homogenate alone or lysates of uninfected cells or cells exposed to normal brain homogenate (Fig. 4a) .
These data confirm that the degradation of PrP Sc by XS106 cells correlated with a significant reduction in the level of scrapie agent infectivity associated with these cells.
Effect of scrapie exposure on the surface expression of costimulatory and activation markers by XS106 cells FACS analysis was used to determine whether the expression of specific surface antigens by XS106 cells was altered following exposure to the scrapie agent. The experiment demonstrated that exposure to the scrapie agent did not significantly change the expression of CD11c, CD40, CD54, CD80, CD86, CD205, Ia k or PrP when compared to cells exposed to normal brain homogenate (Fig. 5) . These data suggest that XS106 cells do not undergo further maturation or activation after in vitroexposure to the scrapie agent.
Immature LC-like cells do not degrade the scrapie agent in vitro
Unlike the XS106 cell line used above, the XS52 cell line is an immature LC-like cell line isolated from mouse epidermis. 19 FACS analysis confirmed that these cells do not express the surface antigens typically associated with LC maturation (CD40, CD80, CD86 and Ia d ; Fig. 6a-d, respectively) , indicating that these cells displayed an immature phenotype when compared to XS106 cells (Fig. 1) . However, XS52 cells expressed PrP C protein (Fig. 6e) . The XS52 cell line was used in parallel studies to determine whether the degradation of PrP Sc by XS106 cells is typical of any in vitrocultivated cell line exposed to the scrapie agent. Under the same experimental conditions, XS52 cells accumulated abundant PrP Sc after 16 hr exposure to scrapie brain homogenate (Fig. 6f) . However, in contrast to XS106 cells exposed to the scrapie agent (Figs 3a and and4a ),4a), there was no progressive decrease in PrP Sc (Fig. 6f) or infectivity (Fig. 4b) over the 96-hr observation period.
LPS inhibits the degradation of PrP Sc by XS106 cells
As non-specific immune stimulation around the time of peripheral inoculation with TSE agents can enhance disease pathogenesis 24 we next investigated the effect of LPS stimulation on PrP Sc degradation by XS106 cells. LCs can bind LPS via Toll-like receptor (TLR)-2 and TLR-4 25, 26 in association with CD14. 27 RT-PCR analysis confirmed that XS106 cells expressed mRNA specific for both TLR-2 ( Fig. 7a ) and TLR-4 (Fig. 7b) . The demonstration that XS cells also express CD14 28 indicates that these cells would have the potential to respond to LPS stimulation. LPS pretreatment appeared to block the degradation of PrP Sc by XS106 cells, as cells stimulated with LPS prior to exposure to the scrapie agent showed no decrease in PrP Sc over the 96-hr observation period (Fig. 7c) .
Discussion
Here we show that LC-like XS106 cells rapidly acquire the scrapie agent following in vitro exposure. After uptake, the PrP Sc and infectivity levels associated with the scrapie agent-exposed XS106 cells were significantly degraded with extended cultivation. These data suggest that LCs might acquire and degrade the scrapie agent Following uptake by DCs, antigens are usually processed into short peptides for presentation to T lymphocytes in association with MHC. However, in some circumstances DCs can retain protein antigens in a native, non-degraded form. 29 The precise fate of the scrapie agent following uptake by DCs is unclear, as studies have shown these cells can retain 16 or degrade PrP Sc . 30 experiments demonstrated that these PrP deposits contained PrP Sc and infectivity which was subsequently degraded following extended cultivation. The mechanism through which XS106 cells degrade the scrapie agent is not known, but may be mediated by cysteine proteases as shown for the degradation of PrP Sc by bone marrow-derived CD11c + myeloid DCs. 31 Accumulations of PrP Sc and infectivity were also detected in association with the highly immature XS52 LC-like cell line following exposure to the scrapie agent. However, the levels of PrP Sc and infectivity associated with this cell line were not subsequently degraded. These data imply that the ability of LCs or DCs to acquire and partially degrade the scrapie agent may be related to the maturation status of the cells.
Exogenous stimuli such as inflammatory cytokines, 32 CpG oligonucleotides 33 and LPS 34 induce the activation and maturation of LCs. Studies by Sethi et al. 35 have shown that treatment of mice with CpG oligonucleotides extended the survival time of scrapie agent-inoculated mice. The effect of CpG treatment on disease pathogenesis was considered to be due to the enhanced clearance of the scrapie agent by TLR-stimulated DCs or macrophages. 35 As LCs 26 and XS106 cells (Fig. 7) express TLR-2 and TLR-4 which bind LPS, we investigated whether LPS-stimulation would enhance the degradation of PrP Sc by XS106 cells. However, we found that LPSstimulation blocked the degradation of PrP Sc by XS106 cells. These data appeared to be in opposition to the hypothesis that TLR-mediated stimulation of the innate immune system enhances the degradation of the scrapie agent. 35 However, subsequent data show that the CpG oligonucleotide treatment protocol used by Sethi et al. 35 destroys lymphoid follicles, 36 the main peripheral site of replication for the scrapie agent. 7, 8 Furthermore, it is unlikely that TLR-mediated stimulation plays an important role in the degradation of the scrapie agent as disease pathogenesis is unaffected in Myd88 -/-mice with defective TLR signalling. 37 The mechanism through which LPS blocks the degradation of PrP Sc by XS106 cells is unknown.
Because LPS-induced proteolytic activity may be accompanied by a down-regulation in antigen uptake via macropinocytosis or Fc-receptors, 38 the loss of PrP Sc degradation by LPS-stimulated XS106 cells may reflect a diminished uptake of the scrapie agent by the cells. Treatment with LPS prior to inoculation with the scrapie agent increases the efficiency of infection. 24 Together these data suggest the effects of LPS treatment on disease pathogenesis might be due to the impaired clearance of the scrapie agent by macrophages or DCs at the site of inoculation.
Indeed, depletion of macrophages before peripheral inoculation with the scrapie agent increases the accumulation of infectivity and PrP Sc in the spleen and shortens the incubation period. 39 DCs in peripheral tissues, including epidermal LCs, are resting cells that continuously endocytose antigens from their local environment. These cells express very low levels of MHC class II and no costimulatory molecules. 13 CD40, CD80 and CD83 on the surface of human monocyte-derived DCs. 44 Whether DCs respond differently to recombinant PrP106−126 and the scrapie agent is not known. The magnitude of surface marker expression on the XS106 cells used in the current study suggests it is unlikely these cells were terminally mature and could not undergo further maturation following scrapie agent exposure. The effect of scrapie exposure on the surface expression of the C-type lectin CD205 was also analysed as this receptor binds carbohydrate residues and delivers them to lysosomes or late endosomes for degradation. 45 Although these cellular compartments have been proposed as sites for PrP Sc degradation, 46-48 expression of CD205 was similarly unaffected following exposure to the scrapie agent.
Following inoculation of mice with the scrapie agent via the skin, neuroinvasion occurs after the agent accumulates in association with FDCs in the draining lymph node. 5, 6 The mechanism through which the scrapie agent is transported to the FDCs within draining lymph node following inoculation via the skin is not known. Upon antigen encounter LCs receive a complex network of signals which stimulate their maturation and migration to draining lymphoid tissue. 13 In mice, inoculation with the scrapie agent does not elicit a specific humoral or cell-mediated immune response. 49, 50 Our data above similarly predict that LCs would not become specifically activated following exposure to the scrapie agent in the epidermis. Thus, although LCs have the potential to acquire and degrade the scrapie agent within the epidermis, our data suggest it is unlikely that these cells become activated and are stimulated to transport the agent to the draining lymph node. Indeed, we have recently demonstrated that when LC migration from the epidermis is blocked, scrapie infectivity is still able to reach the draining lymph node following inoculation via the skin suggesting, that LCs are not major TSE agent transporters. 18 
